Interlaboratory comparison of Epstein-Barr virus viral load assays

American Journal of Transplantation

Volumn 9, Issue 2, 2009, Pages 269-279

  Preiksaitis, J K ^a,b   Pang, X L ^a,b   Fox, J D ^a,c   Fenton, J M ^a   Caliendo, A M ^d   Miller, G G ^e  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

EBV; Interlaboratory variation; Quantitative NAT (QNAT); Standardization; Viral load

Indexed keywords

REAGENT;

ARTICLE; ASSAY; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; KINETICS; LABORATORY TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS LOAD;

BIOLOGICAL ASSAY; CANADA; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EUROPE; HERPESVIRUS 4, HUMAN; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; UNITED STATES; VIRAL LOAD;

EID: 58849134179     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02514.x     Document Type: Article

References (21)

1. Preiksaitis JK, Cockfield SM. Epstein-Barr virus infection and lymphoproliferative disorders after stem cell and solid organ transplantation. In : Bowden RA, Ljungman P, Paya C (eds). Transplant Infections. Philadelphia/New York : Lippincott-Raven, 2003 : 326 349.
2. Green M, Avery RK, Preiksaitis JK eds. Guidelines for the prevention and management of infections complications of solid organ transplantation. Am J of Trans 2004 4 (Suppl.10 59 65.
3. Humar A, Michaels M on behalf of the AST ID Working Group on Infectious Diseases Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006 6 : 262 274.
4. Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: An approach in development. Bone Marrow Transplant 2006 37 : 539 546.
5. Lee TC, Savoldo B, Rooney CM, Heslop HE. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005 5 : 2222 2228.
6. van Esser JW, Niesters HG, Thijsen SF, Meijer E. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 2001 113 : 814 821.
7. Green M, Webber SA. EBV Viral load monitoring: Unanswered questions. Am J Transplant 2002 2 : 894 895.
8. Stevens SJ, Verschuuren EA, Verkuijlen SA, Van Den Brule AJ, Meijer CJ, Middeldorp JM. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk Lymphoma. 2002 43 : 831 840.
9. Andersson M. 1975. Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines. J Virol 16 : 1345 1347.
10. Minowada J, Onuma T, Moore GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 1972 49 : 891 895.
11. Hayden RT, Hokanson KM, Pounds SB et al. for the US EBV Working Group. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol 2008 : 46 : 157 163.
12. Schauer E, Webber S, Green M, Rowe D. Surface immunoglobulin-deficient Epstein-Barr virus-infected B cells in the peripheral blood of pediatric solid-organ transplant recipients. J Clin Microbiol 2004 42 : 5802 5810.
13. Laichalk LI, Thorley-Lawson DA. Terminal Differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005 79 : 1296 1307.
14. Ryan JL, Fan H, Swinnen LJ et al. Epstein-Barr virus (EBV) DNA plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 2004 13 : 61 68.
15. Axelrod DA, Holmes R, Thomas SE, Magee JC. Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder. Pediatr Transplantation 2003 7 : 223 227.
16. Wadowsky RM, Laus S, Green M, Webber A, Rowe D. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol 2003 41 : 5245 5249.
17. Pisani G, Cristiano K, Saldanha J, Wirz M, Bisso GM, Mele C, Gentili G, EQA Participants. External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: The first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5). Vox Sang 2004 87 : 91 95.
18. Saldanha J, Lelie N, Heath A, and the WHO Collaborative Study Group. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang 1999 76 : 149 158.
19. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization International standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001 80 : 63 71.
20. Saldanha, J, Heath A, Lelie N, Pisani G, Yu MW. A World Health Organization International standard for hepatitis A virus RNA nucleic acid amplification technology assays. Vox Sang 2005 89 : 52 58.
21. Saldanha J, Lelie N, Yu MW, Heath A. Establishment of the first World Health Organization International standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002 82 : 24 31.